Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | Looking to the future of screening programs for lung cancer in the UK

David Baldwin • 29 Jan 2020
BTOG 2020
Lung Cancer

David Baldwin, MD, FRCP, University of Nottingham, Nottingham, UK, shares what data he is most looking forward to in 2020 and his highlights from this year’s BTOG meeting. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

More from David Baldwin

3:36
Facilitating the decision-making process for patients during lung cancer screening
David Baldwin • 29 Aug 2023
1:33
Strategies for ensuring the cost-effectiveness of lung cancer screening in the UK
David Baldwin • 29 Aug 2023
1:32
Advancements in the UK’s national screening programme for lung cancer
David Baldwin • 29 Aug 2023
1:26
Highlights from WCLC 2022: CT screening
David Baldwin • 7 Aug 2022

Related Videos

2:38
Phase I trial of binimetinib and pembrolizumab in NSCLC
Natasha Leighl • 17 Apr 2024
2:43
CHRYSALIS: amivantamab in wild-type, pre-treated NSCLC
Natasha Leighl • 17 Apr 2024
3:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat • 19 Apr 2024
2:09
Is there a role for radiotherapy in extensive-stage SCLC?
Clive Peedell • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals